Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 May 17

PMID 32414222

Citations 11

Authors

Divya Thomas

Prakash Radhakrishnan

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer (PC) is the utmost stroma-rich cancer, which is accompanied by fibrotic reactions that stimulate interactions between tumor cells and stroma to promote tumor progression. Considerable research evidence denotes that insulin-like growth factor (IGF)/IGF binding proteins (IGFBP) signaling axis facilitate tumor growth, metastasis, drug resistance, and thereby facilitate PC into an advanced stage. The six members of IGFBPs were initially considered as passive carriers of free IGFs; however, current evidence revealed their functions beyond the endocrine role in IGF transport. Though numerous efforts have been made in blocking IGF/IGFBPs, the targeted therapies remain unsuccessful due to the complexity of tumor-stromal interactions in the pancreas. In this review, we explore the emerging evidence of the various roles of the tumor as well as stroma derived IGF/IGFBPs and highlight as a novel therapeutic target against PC progression.

Citing Articles

β-Sitosterol-Dietary sources and role in cancer and diabetes management.

Adhimoolam K, Sureshbabu A, Smirnova E, Muthuramalingam P, Do Thi C, Senthil K Food Sci Nutr. 2024; 12(11):8870-8886.

PMID: 39619995 PMC: 11606809. DOI: 10.1002/fsn3.4380.

Analysis of IGFBP7 expression characteristics in pan-cancer and its clinical relevance to stomach adenocarcinoma.

Xu H, Wang M, Zhu S Transl Cancer Res. 2023; 12(10):2596-2612.

PMID: 37969374 PMC: 10643967. DOI: 10.21037/tcr-23-1055.

Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment.

Sebastian A, Martin K, Peran I, Hum N, Leon N, Amiri B Front Oncol. 2023; 13:1286861.

PMID: 37954069 PMC: 10639148. DOI: 10.3389/fonc.2023.1286861.

CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.

Wlodarczyk B, Durko L, Wlodarczyk P, Talar-Wojnarowska R, Malecka-Wojciesko E J Clin Med. 2023; 12(12).

PMID: 37373743 PMC: 10299217. DOI: 10.3390/jcm12124050.

The association between red, processed and white meat consumption and risk of pancreatic cancer: a meta-analysis of prospective cohort studies.

Kim Y Cancer Causes Control. 2023; 34(7):569-581.

PMID: 37071321 DOI: 10.1007/s10552-023-01698-8.

References

Seligson D, Yu H, Tze S, Said J, Pantuck A, Cohen P . IGFBP-3 nuclear localization predicts human prostate cancer recurrence. Horm Cancer. 2012; 4(1):12-23. PMC: 3541441. DOI: 10.1007/s12672-012-0124-8. View

Rosendahl A, Gundewar C, Said Hilmersson K, Ni L, Saleem M, Andersson R . Conditionally immortalized human pancreatic stellate cell lines demonstrate enhanced proliferation and migration in response to IGF-I. Exp Cell Res. 2014; 330(2):300-310. DOI: 10.1016/j.yexcr.2014.09.033. View

Liao B, Hu Y, Brewer G . RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem. 2011; 286(36):31145-52. PMC: 3173139. DOI: 10.1074/jbc.M111.263913. View

Berberich A, Kessler T, Thome C, Pusch S, Hielscher T, Sahm F . Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib. Clin Cancer Res. 2018; 25(1):253-265. DOI: 10.1158/1078-0432.CCR-18-1580. View

Xu Q, Li S, Zhao Y, Maures T, Yin P, Duan C . Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells. Circ Res. 2004; 94(5):E46-54. DOI: 10.1161/01.RES.0000124761.62846.DF. View

Lee E, Mircean C, Shmulevich I, Wang H, Liu J, Niemisto A . Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer. 2005; 4(1):7. PMC: 549074. DOI: 10.1186/1476-4598-4-7. View

Jakubowska K, Pryczynicz A, Januszewska J, Sidorkiewicz I, Kemona A, Niewinski A . Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma. Dis Markers. 2016; 2016:9895721. PMC: 4939209. DOI: 10.1155/2016/9895721. View

Leal S, Liu Q, Huang S, Huang J . The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem. 1997; 272(33):20572-6. DOI: 10.1074/jbc.272.33.20572. View

Chu G, Kimmelman A, Hezel A, DePinho R . Stromal biology of pancreatic cancer. J Cell Biochem. 2007; 101(4):887-907. DOI: 10.1002/jcb.21209. View

10.

Sternlicht M, Werb Z . How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17:463-516. PMC: 2792593. DOI: 10.1146/annurev.cellbio.17.1.463. View

11.

Yang J, Waldron R, Su H, Moro A, Chang H, Eibl G . Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2016; 311(4):G675-G687. PMC: 5142202. DOI: 10.1152/ajpgi.00251.2016. View

12.

McCaig C, Perks C, Holly J . Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci. 2002; 115(Pt 22):4293-303. DOI: 10.1242/jcs.00097. View

13.

Rajaram S, Baylink D, Mohan S . Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 1997; 18(6):801-31. DOI: 10.1210/edrv.18.6.0321. View

14.

Bach L, Headey S, Norton R . IGF-binding proteins--the pieces are falling into place. Trends Endocrinol Metab. 2005; 16(5):228-34. DOI: 10.1016/j.tem.2005.05.005. View

15.

Zhu H, Wei M, Xu J, Hua J, Liang C, Meng Q . PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications. Mol Cancer. 2020; 19(1):49. PMC: 7053129. DOI: 10.1186/s12943-020-01167-9. View

16.

Guo C, Lu H, Gao W, Wang L, Lu K, Wu S . Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. PLoS One. 2013; 8(9):e74973. PMC: 3775736. DOI: 10.1371/journal.pone.0074973. View

17.

Martin J, de Silva H, Lin M, Scott C, Baxter R . Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade. Mol Cancer Ther. 2013; 13(2):316-28. DOI: 10.1158/1535-7163.MCT-13-0367. View

18.

Baron-Hay S, Boyle F, Ferrier A, Scott C . Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res. 2004; 10(5):1796-806. DOI: 10.1158/1078-0432.ccr-0672-2. View

19.

Dusch N, Weiss C, Strobel P, Kienle P, Post S, Niedergethmann M . Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas: 40 years of experience. J Gastrointest Surg. 2013; 18(4):674-81. DOI: 10.1007/s11605-013-2408-x. View

20.

Nixon A, Pang H, Starr M, Friedman P, Bertagnolli M, Kindler H . Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance). Clin Cancer Res. 2013; 19(24):6957-66. PMC: 4219241. DOI: 10.1158/1078-0432.CCR-13-0926. View